CLINICAL_TRIALS
trial_result
· 2012-07-11
Clinical Trial Update: Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
Summary
A Phase 2 clinical trial evaluating the combination of imatinib mesylate and cytarabine in patients with chronic myeloid leukemia was terminated, with results p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: OHSU Knight Cancer Institute | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2012-07-11